Spero Therapeutics, Inc. (SPRO) Social Stream



Spero Therapeutics, Inc. (SPRO): $1.21

0.01 (-0.82%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add SPRO to Watchlist
Sign Up

SPERO THERAPEUTICS INC (SPRO) Price Targets From Analysts

Use the tables below to see what analysts covering SPERO THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $47 $25 $34.75 $1.34 2493.28%
2022-02-28 4 $40 $25 $30.666 $1.34 2188.51%
2022-03-21 3 $43 $25 $31.666 $1.34 2263.13%
2022-04-04 4 $43 $25 $31.666 $1.34 2263.13%
2022-04-18 5 $37 $25 $29.666 $1.34 2113.88%
2022-05-03 5 $37 $2 $22 $1.34 1541.79%
2022-05-17 5 $37 $2 $14.666 $1.34 994.48%
2022-05-23 6 $10 $2 $5.666 $1.34 322.84%
2022-08-11 5 $10 $2 $5.666 $1.34 322.84%
2022-09-07 5 $7 $2 $4.666 $1.34 248.21%
2022-09-23 5 $8 $5 $6.666 $1.34 397.46%
2023-01-26 4 $8 $5 $6.333 $1.34 372.61%
2023-04-10 5 $8 $5 $6.333 $1.34 372.61%
2023-08-11 4 $8 $5 $6.333 $1.34 372.61%
2023-08-14 4 $8 $5 $6.666 $1.34 397.46%

The Trend in the Analyst Price Target


SPRO's average price target has moved down $26.21 over the prior 30 months.

SPRO reports an average of 297.72% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-26 5 8 5 6.333 2.09 203.01%
2023-01-26 4 8 5 6.333 1.85 242.32%
2023-01-26 5 8 5 6.333 1.85 242.32%
2023-08-01 4 8 5 6.333 1.52 316.64%
2023-08-14 4 8 5 6.666 1.37 386.57%

SPRO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 15 months, SPRO's average broker recommendation rating improved by 0.7.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SPRO as an investment opportunity.

  • In terms of how SPERO THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1719.79% of that group.
  • SPRO has a greater number of analysts covering the stock than 342.41% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, SPERO THERAPEUTICS INC's average analyst price target is greater than 834.61% of them.
  • In terms of how SPERO THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -827.73% of that group.

Stocks similar to SPERO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RYTM, NCNA, and KALA.

What is the outlook for SPRO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!